US3431339A - Dentifrices - Google Patents
Dentifrices Download PDFInfo
- Publication number
- US3431339A US3431339A US566610A US3431339DA US3431339A US 3431339 A US3431339 A US 3431339A US 566610 A US566610 A US 566610A US 3431339D A US3431339D A US 3431339DA US 3431339 A US3431339 A US 3431339A
- Authority
- US
- United States
- Prior art keywords
- tablet
- agent
- sodium
- teeth
- anticaries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000551 dentifrice Substances 0.000 title description 11
- 239000003795 chemical substances by application Substances 0.000 description 37
- 239000000203 mixture Substances 0.000 description 30
- 238000005498 polishing Methods 0.000 description 21
- 230000001680 brushing effect Effects 0.000 description 17
- 239000000796 flavoring agent Substances 0.000 description 17
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 16
- 229910052731 fluorine Inorganic materials 0.000 description 16
- 239000011737 fluorine Substances 0.000 description 16
- 230000000675 anti-caries Effects 0.000 description 14
- 239000000606 toothpaste Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 11
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 11
- 229960002799 stannous fluoride Drugs 0.000 description 11
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- 239000004088 foaming agent Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 229940034610 toothpaste Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 239000001506 calcium phosphate Substances 0.000 description 7
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 6
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 6
- 239000004075 cariostatic agent Substances 0.000 description 6
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 6
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 6
- 229940038472 dicalcium phosphate Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229940091249 fluoride supplement Drugs 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 239000003349 gelling agent Substances 0.000 description 6
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 244000151018 Maranta arundinacea Species 0.000 description 3
- 235000010804 Maranta arundinacea Nutrition 0.000 description 3
- 235000012419 Thalia geniculata Nutrition 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- PLVVKSPVSVMLET-UHFFFAOYSA-N [Cl-].C(C(C)C)C([NH+](C)CCOCCOC1=CC=CC=C1)CC(C)C Chemical compound [Cl-].C(C(C)C)C([NH+](C)CCOCCOC1=CC=CC=C1)CC(C)C PLVVKSPVSVMLET-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical class O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- FXPVUWKFNGVHIZ-UHFFFAOYSA-L disodium;dodecyl sulfate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O FXPVUWKFNGVHIZ-UHFFFAOYSA-L 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
Definitions
- the tablet contains an intimate blend of water-soluble, anticaries fluorine containing agents, such as stannous fluoride or sodium monofluorophosphate, polishing agent, such as agent including insoluble sodium metaphosphate, foaming agent, such as sodium lauryl sulfate, and releasable matrix, such as waxy polyethylene glycol.
- agents such as stannous fluoride or sodium monofluorophosphate
- polishing agent such as agent including insoluble sodium metaphosphate
- foaming agent such as sodium lauryl sulfate
- releasable matrix such as waxy polyethylene glycol.
- the present invention relates to dentifrices.
- Toothpastes are, of course, the most commonly used dentifrices but, as generally employed, they do not ac complish as thorough a cleaning of the teeth as is desirable.
- One problem arises through carelessness in brushing, particularly a lack of thoroughness in brushing posterior teeth. This is the location where caries occur most frequently.
- Another object of this invention is the provision of a dentifrice containing an anticaries agent which is resistant to loss of activity in the dentifrice on storage.
- a unique compressed dental tablet for use, with a toothbrush, in place of toothpaste.
- the tablet which contains an intimate blend of a water-soluble, anticaries fluorine containing agent, polishing agent, foaming agent and releasable matrix, has upper and lower convex surfaces, has a thickness at its thickest point of about 3 to 20 mm., has a Stokes hardness of about 2.5 to 6.0 kg.
- the size, shape and consistency of the tablet are such that it is readily crushed between the teeth and, when so crushed, breaks up to form simultaneously a multiple combination of (a) powdery material which is released to form with the saliva a slurry containing a nonpalpable polishing agent and which has the effect of a toothpaste slurry and (b) larger, palpable, gritty fragments of the tablet.
- the tablet has a pH of about 4.5-6.5 when slurried in water at 20% concentration. We have found that this substantially improves the cleaning of the lingual surfaces.
- the use of the dental tablet of this invention gave a considerably better removal of plaques and debris from the lingual surfaces than was obtained by the use of toothpaste.
- the tablet preferably has straight sides and has a length of about 8 mm. to 20 mm., a width of about mm. to 13 mm. and the maximum depth of the convexly curved top and bottom is preferably about to 25% of the tablet width.
- it is oblong, most preferably oval.
- the preferred tablet will be oblong in shape so as to better fit between the posterior teeth when used.
- FIGURE 2 is a side view of the tablet, drawn to scale
- FIGURE 3 is a cross-sectional view taken along the line 3-3 of FIGURE 1;
- FIGURE 4 is a view showing the tablet just before it is crushed between the teeth.
- a crushable dental tablet containing a water-soluble, anticaries fluorine containing agent such as stannous fluoride, sodium monofluorophosphate or sodium fluoride in combonation with polishing agent, forming agent, a releasable matrix, all in a substantially anhydrous form.
- a water-soluble, anticaries fluorine containing agent such as stannous fluoride, sodium monofluorophosphate or sodium fluoride in combonation with polishing agent, forming agent, a releasable matrix, all in a substantially anhydrous form.
- the amount of moisture in the tablet should preferably not exceed about 1%.
- the tablet contains the anticaries fluorine containing agent, a stabilizer for the anticaries fluorine containing agent, a surface active foaming agent, a releasable matrix, and an agent to promote disintegration and a gelling agent together with a flavoring agent and an absorbent for the flavoring agent.
- the preferred active anticaries ingredients are stannous fluoride and sodium monofluorophosphate, which are preferably supplied in finely divided form, e.g., having a particle size in the range of about 880 microns to 1,800 microns. This is considerably finer than the material conventionally employed in making toothpaste where a coarse agent, such as stannous fluoride, is dissolved in water.
- the amount of anticaries agent in the tablet may be varied but should provide an effective, nontoxic amount containing above 0.01% fluoride ppm.) per tablet.
- the maximum fluoride content of the tablet is typically about 1%.
- the preferred fluoride content is about 0.076 to 0.3%, say 0.1%.
- stannous fluoride when employed, would be typically in amount of about 0.04 to 4.1%, preferably about 0.3 to 1.24%, say 0.4%.
- Sodium monofluorophosphate when employed, would be typically in amount of about 0.076 to 7.6%, preferably about 0.57 to 2.3%, say 0.76%.
- active ingredients such as stannous fluoride or sodium monofluorophosphate.
- examples of such ingredients are quaternary ammonium salts such as diisobutylphenoxyethoxyethyl dimethyl ammonium chloride.
- urea may be employed in certain of the compositions when packaged in moisture retardant packages.
- the preferred polishing agents are insoluble phosphate salts, most preferably the insoluble sodium metaphosphate which has been found to be compatible with Water-soluble, anticaries fluorine-containing agent.
- Other specific polishing agents include insoluble potassium metaphosphate, calcium pyrophosphate, magnesium orthophosphate, trimagnesium phosphate, tricalcium phosphate and dicalcium phosphate dihydrate, calcium carbonate, anhydrous dicalcium phosphate and alumina. It is also within the broader scope of the invention to employ other dental cleaning abrasives, which will not scratch the enamel surface of the teeth or abrade the dentin, such as calcium or magnesium carbonate, particularly when active ingredients other than fluorides are used in the tablet.
- This invention permits the use of combinations of fluorides and polishing agents which heretofore were not used in toothpaste.
- Many polishing agents. contain calcium and cannot be used in fluoride containing toothpastes because the calcium reacts with the fluoride salt and reduces the available fluorine.
- cost of polishing agent is of importance, it is possible to select the cheapest polishing agent for a far larger group of compounds and to use the polishing agent as a powder.
- the average particle size of the polishing agent may be the same as that usually employed for dentifrices, e.g., in the range of about 2 to 6 microns, preferably 3.5 to microns, with about 99.9% of the polishing agent passing a standard 200 mesh sieve which has openings about 0.074 mm.
- the amount of polishing agent in the composition is advantageously in the range of about to 95%, preferably about 50 to 85%.
- Insoluble sodium metaphosphate often contains a soluble impurity, soluble sodium trimetaphosphate.
- a material which inactivates or neutralizes this soluble impurity such as anhydrous dicalcium phosphate.
- suitable inactivators would be any of the slightly soluble magnesium or aluminum phosphates.
- a suitable proportion of the anhydrous dicalcium phosphate is up to about 5% by weight of the insoluble sodium metaphosphate.
- the foaming agent in the composition may be any of those surface active agents employed as detergents and sudsing agents in dentifrices.
- Water-soluble sulfates of compounds having long chain alkyl radicals are suitable.
- One preferred material is a long chain fatty acid rnonoglyceride sulfate, such as the sodium salt of hydrogenated coco fatty acid rnonoglyceride sulfate used alone or in combination with sodium lauryl sulfate.
- Other suitable materials are the fatty acid amides of amino acids such as sodium N-lauroyl sarcosinate.
- the proportion of the detergent is advantageously in the range of about l-10%.
- the releasable matrix in the composition is a binder which serves to unite the fine particles of the composition into a coherent mass when the composition is compressed as a tablet.
- a particularly suitable binder is a waxy polyethylene glycol, such as a polyethylene glycol of average weight of about 300 to 8,000, e.g. the products sold as Carbowax 6000 and Carbowax 4000.
- the binder ingredient in a finely divided solid condition, e.g., in the form of fine particles which will pass a US. Standard 80 mesh screen (which has openings about 0.177 mm. in diameter) and preferably a 100 mesh screen (which has openings about 0.149 mm. in diameter).
- compositions of this invention also contain a small amount of a gelling or thickening agent which helps to produce a stronger foam on brushing.
- Suitable gelling agents are generally natural and synthetic gums and gumlike materials, such as sodium carboxymethyl cellulose, Irish Moss, gum tragacanth, gum acacia, gelatin, sodium alginate, methyl cellulose, polyvinyl-pyrroli done and the like.
- the proportion of gelling agent in the composition is advantageously in the range of up to about 2%.
- the stability of the stannous fluoride in the composition may be enhanced by the inclusion of tetrasodium pyrophosphate, advantageously present in proportions in the range of about 0.1% to 0.4% based on the weight of the composition. Less preferably, other nontoxic sequestering agents may be employed together with, or in place of, the tetrasodium pyrophosphate.
- the final disintegration of the tablet in the saliva is promoted by the presence of small amounts of starch, e.g., in amounts up to about 4%, that, about 0 to 4%, preferably about 2 to 3%, Arrowroot starch, corn starch, purified cellulose, olginic acid, methyl cellulose and the like are particularly suitable for this purpose.
- starch e.g., in amounts up to about 4%, that, about 0 to 4%, preferably about 2 to 3%
- Arrowroot starch, corn starch, purified cellulose, olginic acid, methyl cellulose and the like are particularly suitable for this purpose.
- flavoring oils e.g. menthol or oils of Spearmint, peppermint, Wintergreen or fruit flavors alone or in combination, may be used in the composition in amount suflicient to give the desired flavor, generally less than about 2%.
- the flavor oil is desirably absorbed on a finely divided flavor retainer.
- a preferred flavor retainer is very finely divided silica (e.g., having a particle size of under one micron, and a correspondingly large surface area).
- Other flavor retainers known in the art, may also be used, e.g., the natural gums such as gum karaya and gum arabic. Microcrystalline cellulose has also given good results as a flavor retainer.
- the amount of flavor retainer to be used is in part dependent on the amount of flavoring agent in the composition; in general the amount of flavor retainer is about 0.5 to 3.0%.
- a sweetening agent such as sodium saccharin or sodium, potassium and calcium alts of cyclohexylsulf-amic acid is advantageously added in amounts up to about 0.67%.
- a lubricant in the composition to aid in its processing in the tabletting machinery.
- Talc is excellent for this purpose.
- Magnesium and calcium stearate are also suitable.
- the proportion of lubricant is generally in the range of about 0.1 to 5% by Weight.
- mannitol is included. This ingredient aids in the disintegration of the table-t in the saliva of the mouth and improves the smoothness of the tablet during disintegration, thereby permitting the tablet to melt readily in the mouth. It also enhances the flavor and sweetness of the mixture.
- the amount of mannitol is advantageously in the range of up to 50% of the composition.
- finely divided cellulose in the composition, in amounts up to about 10%, enhances the effect of the binder and also aids in the disintegration of the tablet in the saliva of the mouth. It also serves as a filler.
- Suitable coloring agents may be incorporated in the mixture for esthetic effect.
- the moisture content of the tablet is desirably less than about 1%, e.g. about 0.5 to 1.0%.
- the tablet when made into a 20% solids slurry will have a pH of 5 .06.0.
- the insoluble powdered abrasives or polishing agents and the powdered releasable matrix binder in a powder mixer, than add the water soluble anticaries fluorine-containing powder together with the foaming agent, all in dry condition, to the mixer.
- a stabilizer for the anticaries agent and a gelling agent may also be blended together with the anticaries agent and the foaming agent.
- the flavoring agent, sweetener (e.g., saccharin) and flavor retainer may then be separately blended to form a dry powdery mass which is then blended thoroughly in the powder mixer with the previously mentioned mixed ingredients.
- the disintegrators and fillers, in dry, powdered condition may then be incorporated.
- the powdered talc Prior to tabletting the powdered talc may be mixed thoroughly with the powder. The mixture is then fed to a suitable tablet press, such as a rotary tablet press, where it is compressed at a pressure high enough to produce a tablet of the desired hardness, generally about 350-l,400 kg./sq. cm. In the case of the preferred compositions, this pressure is about 1,125 kg./sq. cm.
- a suitable tablet press such as a rotary tablet press
- the preferred tablet contains a unit dosage for dental use, say about 500550 mg, typically about 520 mg.
- EXAMPLE 1 The tablet was made up of the following composition.
- the ingredients were blended in the manner previously described and compressed in a tabletting machine at a pressure of 1,125 kg./ sq. cm. to produce tablet slugs.
- the slugs were crushed through an 8-12 U.S. standard mesh screen (having openings 2.38-1.68 mm. in diameter) and the resulting granules were tab'letted at 1,125 kg./ sq. cm. to produce tablets having a Stokes hardness of 3-4.5 kgs.
- Each tablet had the doubly convex shape 4 illustrated in the drawing (which is drawn to scale) and was 0.127 cm. long and 0.0724 cm. wide and, at its thickest point, Was 0.0524 cm. thick.
- Each tablet had a circumferential straight-sides surface band (reference numeral 3) 0.0318 cm. in height, whose straight sides 4 were parallel to the short (thickness) axis of the tablet.
- EXAMPLE 2 The tablet was made up of the following composition.
- Tetrasodium pyrophosphate 0.4 Sodium salt of hydrogenated coco fatty acid monoglyceride sulfate 2 Sodium lauryl sulfate 0.5 Sodium carboxymethylcellulose (CMC-7 MP) 1.25 Silica (particle size 0015-0020 micron, Cab- O-Sil M-5) 1.25 Flavoring oil 1.75 Sodium saccharin 0.325 Finely divided woodpulp cellulose (Solka Floc BW 100) 5.475 Mannitol (N.F.) 5 Arrowroot starch 2.5 Alabama talc (-U.S.P.) 2
- the tablets were made in the manner previously described by blending, compressing at 1,125 kg./sq. cn1., crushing, and tabletting at 1,125 kg/sq. cm. thereby obtaining tablets having a Stokes hardness of 3-4.5 'kgs.
- Each tablet had the doubly convex shape illustrated in the drawing (which is drawn to scale) and was 0.127 cm. long and 0.0724 cm. wide and, at its thickest point, was 0.0524 cm. thick.
- Each tablet had a circumferential straight-sides surface band (Reference numeral 3) 0.0318 cm. in height, whose straight sides were parallel to the short (thickness) axis of the tablet.
- the average user naturally bites down on it with the posterior teeth, usually crushing the tablet between the .first molar and either a bicuspid or another molar.
- dentifrice then follows the usual food paths in and around the posterior teeth.
- the bits and pieces formed (together with powder) when the dentifrice is crushed make the user more apt (than when toothpaste is used) to clean away food debris that collects in the interproximals and along gingival margins. Because the user feels the presence of these particles he tends to continue brushing until the particles are removed. In this way the user is automatically encouraged to brush the buccal surfaces of posterior teeth and the lingual surfaces of all teeth, and thus to clean more thoroughly the areas where caries occur most frequently.
- fluoride-containing tablets of this invention have demonstrated much better retention of their content of active material on storage than fluoride-containing toothpaste.
- a dental tablet crushable with the teeth into powdery material containing a polishing agent and larger palpable, gritty fragments for use in the brushing of teeth with a toothbrush comprising an intimate blend of watersoluble, anticaries, fluorine-containing agent selected from the group consisting of stannous fluoride and sodium monofiuorophosphate in an amount to provide a fluorine content in said tablet of about 0.01% to 1% by weight, about 20% to 95% by weight of a polishing agent, about 1% to 10% by Weight of foaming agent, and about 4% g to 20% of waxy releasable matrix selected from the group consisting of a polyethylene glycol, tristearin and paraffin; said tablet having a moisture content up to about 0.01% to about 1% by weight, said tablet having upper and lower convex surfaces, a thickness at its thickest point of about 3 to 20 'mm. and a Stokes hardness of about 2.5 to 6.0 kgs.; said tablet having a pH of about 4.5 to 6.5 when s
- a dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said tablet has a length of about 8 mm. to 20 rnnr, a width of about 5 mm. to 13 mm. and the maximum depth of the convexly curved top and bottom is preferably about to 25% of the width of said tablet.
- a dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said tablet contains a unit dosage for dental use and comprises about 0.49 to 0.55 mg. of fluorine provided by said watersoluble, anticaries fluorine-containing compound, about 331.6 to 366.5 :mg. of said polishing agent, about 12.35 to 13.65 mg. of said foaming agent and about 49.3 to 54.7 mg. of said releasable matrix.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Description
March 4, 1969 K. w. GYARMATHY ETAL 3,431,339
DENTIFRICES Filed July 20, 1966 INVENTORS. KENNETH WILLIAM GYARMATHY BY ALEXANDER WILLIAM BOUCHAL ATTORNEY United States Patent 3,431,339 DENTIFRICES Kenneth W. Gyarmathy, Old Bridge, and Alexander W.
Bouchal, Westfield, N.J., assignors to Colgate-Palmolive Company, New York, N.Y., a corporation of Delaware Filed July 20, 1966, Ser. No. 566,610
US. Cl. 42452 12 Claims Int. Cl. A61k 7/16 ABSTRACT OF THE DISCLOSURE Dental tablet for use in place of toothpaste. The tablet contains an intimate blend of water-soluble, anticaries fluorine containing agents, such as stannous fluoride or sodium monofluorophosphate, polishing agent, such as agent including insoluble sodium metaphosphate, foaming agent, such as sodium lauryl sulfate, and releasable matrix, such as waxy polyethylene glycol.
The present invention relates to dentifrices.
Toothpastes are, of course, the most commonly used dentifrices but, as generally employed, they do not ac complish as thorough a cleaning of the teeth as is desirable. One problem arises through carelessness in brushing, particularly a lack of thoroughness in brushing posterior teeth. This is the location where caries occur most frequently.
In addition, while toothpastes containing anticaries agents such as stannous fluoride have been widely used, it has been found that the activity of the added agent may diminish substantially on storage depending upon the particular formulation.
It is therefore an object of this invention to provide a dentifrice which promotes more thorough cleaning of the posterior teeth on brushing.
Another object of this invention is the provision of a dentifrice containing an anticaries agent which is resistant to loss of activity in the dentifrice on storage.
Other objects of this invention will be apparent from the following detailed description and claims. In this description and claims, all proportions are by weight unless otherwise indicated.
In accordance with one aspect of this invention, there is provided a unique compressed dental tablet for use, with a toothbrush, in place of toothpaste. The tablet, which contains an intimate blend of a water-soluble, anticaries fluorine containing agent, polishing agent, foaming agent and releasable matrix, has upper and lower convex surfaces, has a thickness at its thickest point of about 3 to 20 mm., has a Stokes hardness of about 2.5 to 6.0 kg. The size, shape and consistency of the tablet are such that it is readily crushed between the teeth and, when so crushed, breaks up to form simultaneously a multiple combination of (a) powdery material which is released to form with the saliva a slurry containing a nonpalpable polishing agent and which has the effect of a toothpaste slurry and (b) larger, palpable, gritty fragments of the tablet. The tablet has a pH of about 4.5-6.5 when slurried in water at 20% concentration. We have found that this substantially improves the cleaning of the lingual surfaces. Thus, in comparative tests, the use of the dental tablet of this invention gave a considerably better removal of plaques and debris from the lingual surfaces than was obtained by the use of toothpaste.
The tablet preferably has straight sides and has a length of about 8 mm. to 20 mm., a width of about mm. to 13 mm. and the maximum depth of the convexly curved top and bottom is preferably about to 25% of the tablet width. Advantageously it is oblong, most preferably oval. The preferred tablet will be oblong in shape so as to better fit between the posterior teeth when used.
A preferred form of tablet in accordance with this invention is illustrated in the drawing, in Which ITIGURE l is the top view of the tablet, drawn to sea e;
FIGURE 2 is a side view of the tablet, drawn to scale;
FIGURE 3 is a cross-sectional view taken along the line 3-3 of FIGURE 1;
FIGURE 4 is a view showing the tablet just before it is crushed between the teeth.
In accordance with this invention there is provided a crushable dental tablet containing a water-soluble, anticaries fluorine containing agent such as stannous fluoride, sodium monofluorophosphate or sodium fluoride in combonation with polishing agent, forming agent, a releasable matrix, all in a substantially anhydrous form. The amount of moisture in the tablet should preferably not exceed about 1%. We have found that the anticaries agent in such a dry tablet retains its effectiveness on storage for very long periods of time, in sharp contrast to the deterioration which takes place in toothpaste.
In a preferred embodiment of the invention, the tablet contains the anticaries fluorine containing agent, a stabilizer for the anticaries fluorine containing agent, a surface active foaming agent, a releasable matrix, and an agent to promote disintegration and a gelling agent together with a flavoring agent and an absorbent for the flavoring agent.
The preferred active anticaries ingredients are stannous fluoride and sodium monofluorophosphate, which are preferably supplied in finely divided form, e.g., having a particle size in the range of about 880 microns to 1,800 microns. This is considerably finer than the material conventionally employed in making toothpaste where a coarse agent, such as stannous fluoride, is dissolved in water. The amount of anticaries agent in the tablet may be varied but should provide an effective, nontoxic amount containing above 0.01% fluoride ppm.) per tablet. The maximum fluoride content of the tablet is typically about 1%. The preferred fluoride content is about 0.076 to 0.3%, say 0.1%. Thus stannous fluoride, when employed, would be typically in amount of about 0.04 to 4.1%, preferably about 0.3 to 1.24%, say 0.4%. Sodium monofluorophosphate, when employed, would be typically in amount of about 0.076 to 7.6%, preferably about 0.57 to 2.3%, say 0.76%. It is within the scope of this invention to use other active ingredients together with the anticaries fluorine-containing agent such as stannous fluoride or sodium monofluorophosphate. Examples of such ingredients are quaternary ammonium salts such as diisobutylphenoxyethoxyethyl dimethyl ammonium chloride. In addition urea may be employed in certain of the compositions when packaged in moisture retardant packages.
The preferred polishing agents are insoluble phosphate salts, most preferably the insoluble sodium metaphosphate which has been found to be compatible with Water-soluble, anticaries fluorine-containing agent. Other specific polishing agents include insoluble potassium metaphosphate, calcium pyrophosphate, magnesium orthophosphate, trimagnesium phosphate, tricalcium phosphate and dicalcium phosphate dihydrate, calcium carbonate, anhydrous dicalcium phosphate and alumina. It is also within the broader scope of the invention to employ other dental cleaning abrasives, which will not scratch the enamel surface of the teeth or abrade the dentin, such as calcium or magnesium carbonate, particularly when active ingredients other than fluorides are used in the tablet.
This invention permits the use of combinations of fluorides and polishing agents which heretofore were not used in toothpaste. Many polishing agents. contain calcium and cannot be used in fluoride containing toothpastes because the calcium reacts with the fluoride salt and reduces the available fluorine. Thus, where cost of polishing agent is of importance, it is possible to select the cheapest polishing agent for a far larger group of compounds and to use the polishing agent as a powder. The average particle size of the polishing agent may be the same as that usually employed for dentifrices, e.g., in the range of about 2 to 6 microns, preferably 3.5 to microns, with about 99.9% of the polishing agent passing a standard 200 mesh sieve which has openings about 0.074 mm. in diameter and well over 95%, typically 99%, passing a standard 325 mesh sieve (which has openings about 0.044 mm. in diameter). The amount of polishing agent in the composition is advantageously in the range of about to 95%, preferably about 50 to 85%.
Insoluble sodium metaphosphate often contains a soluble impurity, soluble sodium trimetaphosphate. In order to avoid certain undesirable effects of the sodium trimetaphosphate, it is preferable to include in the composition a material which inactivates or neutralizes this soluble impurity such as anhydrous dicalcium phosphate. Other suitable inactivators would be any of the slightly soluble magnesium or aluminum phosphates. A suitable proportion of the anhydrous dicalcium phosphate is up to about 5% by weight of the insoluble sodium metaphosphate.
The foaming agent in the composition may be any of those surface active agents employed as detergents and sudsing agents in dentifrices. Water-soluble sulfates of compounds having long chain alkyl radicals (e.g., chains of 10 to 18 carbon atoms) are suitable. One preferred material is a long chain fatty acid rnonoglyceride sulfate, such as the sodium salt of hydrogenated coco fatty acid rnonoglyceride sulfate used alone or in combination with sodium lauryl sulfate. Other suitable materials are the fatty acid amides of amino acids such as sodium N-lauroyl sarcosinate. The proportion of the detergent is advantageously in the range of about l-10%.
The releasable matrix in the composition is a binder which serves to unite the fine particles of the composition into a coherent mass when the composition is compressed as a tablet. A particularly suitable binder is a waxy polyethylene glycol, such as a polyethylene glycol of average weight of about 300 to 8,000, e.g. the products sold as Carbowax 6000 and Carbowax 4000. In the manufacture of the tablets we have found it highly advantageous to supply the binder ingredient in a finely divided solid condition, e.g., in the form of fine particles which will pass a US. Standard 80 mesh screen (which has openings about 0.177 mm. in diameter) and preferably a 100 mesh screen (which has openings about 0.149 mm. in diameter). Particularly good results have been obtained, in the manufacturing procedure, by bringing the fine binder particles into contact with the much more finely divided polishing agent before the substantial addition of the other ingredients of the composition. In place of the waxy polyethylene glycol, other waxy material such as tristearin, paraflin and the like may be used. The amount of binder is advantageously in the range of about 420% of the composition.
The preferred compositions of this invention also contain a small amount of a gelling or thickening agent which helps to produce a stronger foam on brushing. Suitable gelling agents are generally natural and synthetic gums and gumlike materials, such as sodium carboxymethyl cellulose, Irish Moss, gum tragacanth, gum acacia, gelatin, sodium alginate, methyl cellulose, polyvinyl-pyrroli done and the like. The proportion of gelling agent in the composition is advantageously in the range of up to about 2%.
The stability of the stannous fluoride in the composition may be enhanced by the inclusion of tetrasodium pyrophosphate, advantageously present in proportions in the range of about 0.1% to 0.4% based on the weight of the composition. Less preferably, other nontoxic sequestering agents may be employed together with, or in place of, the tetrasodium pyrophosphate.
The final disintegration of the tablet in the saliva is promoted by the presence of small amounts of starch, e.g., in amounts up to about 4%, that, about 0 to 4%, preferably about 2 to 3%, Arrowroot starch, corn starch, purified cellulose, olginic acid, methyl cellulose and the like are particularly suitable for this purpose.
Any suitable flavoring oils, e.g. menthol or oils of Spearmint, peppermint, Wintergreen or fruit flavors alone or in combination, may be used in the composition in amount suflicient to give the desired flavor, generally less than about 2%. The flavor oil is desirably absorbed on a finely divided flavor retainer. A preferred flavor retainer is very finely divided silica (e.g., having a particle size of under one micron, and a correspondingly large surface area). Other flavor retainers, known in the art, may also be used, e.g., the natural gums such as gum karaya and gum arabic. Microcrystalline cellulose has also given good results as a flavor retainer. The amount of flavor retainer to be used is in part dependent on the amount of flavoring agent in the composition; in general the amount of flavor retainer is about 0.5 to 3.0%.
To contribute desirable sweetness to the taste of the flavor, a sweetening agent such as sodium saccharin or sodium, potassium and calcium alts of cyclohexylsulf-amic acid is advantageously added in amounts up to about 0.67%.
It is advantageous to include a lubricant in the composition to aid in its processing in the tabletting machinery. Talc is excellent for this purpose. Magnesium and calcium stearate are also suitable. The proportion of lubricant is generally in the range of about 0.1 to 5% by Weight.
In the preferred compositions of this invention, mannitol is included. This ingredient aids in the disintegration of the table-t in the saliva of the mouth and improves the smoothness of the tablet during disintegration, thereby permitting the tablet to melt readily in the mouth. It also enhances the flavor and sweetness of the mixture. The amount of mannitol is advantageously in the range of up to 50% of the composition.
The inclusion of finely divided cellulose in the composition, in amounts up to about 10%, enhances the effect of the binder and also aids in the disintegration of the tablet in the saliva of the mouth. It also serves as a filler.
Suitable coloring agents may be incorporated in the mixture for esthetic effect. The moisture content of the tablet is desirably less than about 1%, e.g. about 0.5 to 1.0%. Preferably the tablet when made into a 20% solids slurry will have a pH of 5 .06.0.
In the manufacture of the tablet it is advantageous to first blend the insoluble powdered abrasives or polishing agents and the powdered releasable matrix binder in a powder mixer, than add the water soluble anticaries fluorine-containing powder together with the foaming agent, all in dry condition, to the mixer. A stabilizer for the anticaries agent and a gelling agent may also be blended together with the anticaries agent and the foaming agent. The flavoring agent, sweetener (e.g., saccharin) and flavor retainer may then be separately blended to form a dry powdery mass which is then blended thoroughly in the powder mixer with the previously mentioned mixed ingredients. The disintegrators and fillers, in dry, powdered condition, may then be incorporated. Prior to tabletting the powdered talc may be mixed thoroughly with the powder. The mixture is then fed to a suitable tablet press, such as a rotary tablet press, where it is compressed at a pressure high enough to produce a tablet of the desired hardness, generally about 350-l,400 kg./sq. cm. In the case of the preferred compositions, this pressure is about 1,125 kg./sq. cm.
In accordance with certain aspects of this invention, the preferred tablet contains a unit dosage for dental use, say about 500550 mg, typically about 520 mg.
EXAMPLE 1 The tablet was made up of the following composition.
Ingredients: Parts by weight Insoluble sodium metaphosphate (microcrystalline powder of food grade purity) 61.13 Anhydrous dicalcium phosphate (microcrystalline powder, food grade purity, meeting NFXI purity limits) 6 Polyethylene glycol having an average molecular weight of 6,000-7,500 (Carbowax 6000) 10 F.C. & C. Blue #1 Lake (Blue #1, 10%
precipitated on alumina substrate 0.017 F.D. & C. Violet #1 Lake (Violet #1, 10%
precipitated on alumina substrate) 0.017 Stannous fluoride 0.4 Tetrasodium pyrophosphate 0.4
Sodium salt of hydrogenated coco fatty acid monoglyceride sulfate 2 Sodium lauryl sulfate Sodium carboxymethylcellulose (CMC-7 MP) 1.25 Silica (particle size 0.015-0.020 micron, Cab- O-Sil M-S) 1.25 Flavoring oil Sodium saccharin 0.325 Finely divided woodpulp cellulose (Solka Floc BW 100) 5.475 Mannitol (Nil?) 5 Arrowroot starch 2.5 Alabama talc (U.S.P.) 2
The ingredients were blended in the manner previously described and compressed in a tabletting machine at a pressure of 1,125 kg./ sq. cm. to produce tablet slugs. The slugs were crushed through an 8-12 U.S. standard mesh screen (having openings 2.38-1.68 mm. in diameter) and the resulting granules were tab'letted at 1,125 kg./ sq. cm. to produce tablets having a Stokes hardness of 3-4.5 kgs. Each tablet had the doubly convex shape 4 illustrated in the drawing (which is drawn to scale) and was 0.127 cm. long and 0.0724 cm. wide and, at its thickest point, Was 0.0524 cm. thick. Each tablet had a circumferential straight-sides surface band (reference numeral 3) 0.0318 cm. in height, whose straight sides 4 were parallel to the short (thickness) axis of the tablet.
EXAMPLE 2 The tablet was made up of the following composition.
6 Ingredients: Parts by weight Tetrasodium pyrophosphate 0.4 Sodium salt of hydrogenated coco fatty acid monoglyceride sulfate 2 Sodium lauryl sulfate 0.5 Sodium carboxymethylcellulose (CMC-7 MP) 1.25 Silica (particle size 0015-0020 micron, Cab- O-Sil M-5) 1.25 Flavoring oil 1.75 Sodium saccharin 0.325 Finely divided woodpulp cellulose (Solka Floc BW 100) 5.475 Mannitol (N.F.) 5 Arrowroot starch 2.5 Alabama talc (-U.S.P.) 2
The tablets were made in the manner previously described by blending, compressing at 1,125 kg./sq. cn1., crushing, and tabletting at 1,125 kg/sq. cm. thereby obtaining tablets having a Stokes hardness of 3-4.5 'kgs. Each tablet had the doubly convex shape illustrated in the drawing (which is drawn to scale) and was 0.127 cm. long and 0.0724 cm. wide and, at its thickest point, was 0.0524 cm. thick. Each tablet had a circumferential straight-sides surface band (Reference numeral 3) 0.0318 cm. in height, whose straight sides were parallel to the short (thickness) axis of the tablet.
When the tablets of each of the examples are used, the average user naturally bites down on it with the posterior teeth, usually crushing the tablet between the .first molar and either a bicuspid or another molar. The
dentifrice then follows the usual food paths in and around the posterior teeth. The bits and pieces formed (together with powder) when the dentifrice is crushed make the user more apt (than when toothpaste is used) to clean away food debris that collects in the interproximals and along gingival margins. Because the user feels the presence of these particles he tends to continue brushing until the particles are removed. In this way the user is automatically encouraged to brush the buccal surfaces of posterior teeth and the lingual surfaces of all teeth, and thus to clean more thoroughly the areas where caries occur most frequently.
In addition, the fluoride-containing tablets of this invention have demonstrated much better retention of their content of active material on storage than fluoride-containing toothpaste.
Although the present invention has been described with reference to particular embodiments and examples, it will be apparent to those skilled in the art that variations and modifications of this invention can be made and that equivalents can be substituted therefor without departing from the principles and true spirit of the invention.
We claim:
1. A dental tablet crushable with the teeth into powdery material containing a polishing agent and larger palpable, gritty fragments for use in the brushing of teeth with a toothbrush comprising an intimate blend of watersoluble, anticaries, fluorine-containing agent selected from the group consisting of stannous fluoride and sodium monofiuorophosphate in an amount to provide a fluorine content in said tablet of about 0.01% to 1% by weight, about 20% to 95% by weight of a polishing agent, about 1% to 10% by Weight of foaming agent, and about 4% g to 20% of waxy releasable matrix selected from the group consisting of a polyethylene glycol, tristearin and paraffin; said tablet having a moisture content up to about 0.01% to about 1% by weight, said tablet having upper and lower convex surfaces, a thickness at its thickest point of about 3 to 20 'mm. and a Stokes hardness of about 2.5 to 6.0 kgs.; said tablet having a pH of about 4.5 to 6.5 when slurried in water at 20% concentration.
2. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said tablet further comprises about 0.1% to 0.4% by weight of a stabilizer for said water-soluble anticaries containing agent, up to about 4% by weight of an agent to promote disintegration, up to about 2% by weight of a gelling agent, less than about 2% of a flavoring agent and about 0.5 to 3.0% of an absorbent for said flavoring agent.
3. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said watersoluble anticaries fluorine-containing compound is stannous fluoride.
4. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said waxy releasable matrix is a polyethylene glycol.
5. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said tablet has a length of about 8 mm. to 20 rnnr, a width of about 5 mm. to 13 mm. and the maximum depth of the convexly curved top and bottom is preferably about to 25% of the width of said tablet.
6. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said tablet contains a unit dosage for dental use and comprises about 0.49 to 0.55 mg. of fluorine provided by said watersoluble, anticaries fluorine-containing compound, about 331.6 to 366.5 :mg. of said polishing agent, about 12.35 to 13.65 mg. of said foaming agent and about 49.3 to 54.7 mg. of said releasable matrix.
7. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said fluorine content of said tablet is about 0.076 to 0.3% by weight.
8. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 7 wherein said watersoluble anticaries fluorine-containing compound is sodium monofluorophosphate.
9. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said polishing agent is a powdered insoluble phosphate salt having an average particle size of about 2 to 6 microns.
10. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 9 wherein said polishing agent comprises sodium metaphosphate and anhydrous dicalcium phosphate, said anhydrous dicalcium phosphate being present in amount up to 5% by weight of said sodium metaphosphate.
11. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 1 wherein said foaming agent is a surface active detergent.
12. A dental tablet for use in brushing of teeth with a toothbrush as claimed in claim 11 wherein said surface active detergent is selected from the group consisting of sodium N-lauroyl sarcosinate, sodium lauryl sulfate, and the sodium salt of hydrogenated coco fatty acid monoglyceride sulfate.
References Cited UNITED STATES PATENTS 834,676 10/1906 Luyties 16793 840,738 1/1907 Barnard 16793 3,116,208 12/1963 Emond 167-93 3,227,617 1/1966 Manahan et a1.
RICHARD L. H'UFF, Primary Examiner.
U.S. C1. X.R. 42457, 49
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,431,339 March 4, 1969 Kenneth W. Gyarmathy et a1.
It is certified that error appears in the above identified patent and that said Letters Patent are hereby corrected as shown below:
In the heading to the printed specification, lines 3 and 4, "Kenneth W. Gyarmathy, Old Bridge, and Alexander W. Bouchal, Westfield, N. J." should read Kenneth William Gyarmathy, Old Bridge, and Alexander William Bouchal, Westfield, N. J.
Signed and sealed this 7th day of April 1970.
(SEAL) Attest:
WILLIAM E. SCHUYLER, JR.
Commissioner of Patents Edward M. Fletcher, Jr.
Attesting Officer
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56661066A | 1966-07-20 | 1966-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3431339A true US3431339A (en) | 1969-03-04 |
Family
ID=24263606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US566610A Expired - Lifetime US3431339A (en) | 1966-07-20 | 1966-07-20 | Dentifrices |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3431339A (en) |
Cited By (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3962417A (en) * | 1974-03-27 | 1976-06-08 | Howell Charles J | Dentifrice |
| US4071614A (en) * | 1975-06-03 | 1978-01-31 | Colgate Palmolive Company | Dentifrice containing encapsulated flavoring |
| US4157386A (en) * | 1978-05-18 | 1979-06-05 | Rochelle Paul J | Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing |
| US4169885A (en) * | 1977-03-19 | 1979-10-02 | Blendax-Werke R. Schneider Gmbh & Co. | Dental and oral hygiene preparations |
| US4202878A (en) * | 1974-09-20 | 1980-05-13 | The Procter & Gamble Company | Compositions of matter for coloring toothpaste and method of preparing same |
| US4203966A (en) * | 1977-08-22 | 1980-05-20 | William F. McCord | Dentifrice with topical and systemic phosphate fluoride system |
| US4292306A (en) * | 1978-12-28 | 1981-09-29 | Faunce Frank R | Dentifrice with topical and systemic phosphate fluoride system |
| US4308252A (en) * | 1979-10-31 | 1981-12-29 | Young Dental Mfg. Co. | Dentifrice composition |
| US4367218A (en) * | 1979-09-06 | 1983-01-04 | Jacobson Jerry I | Anti-caries oral rinse |
| FR2516792A1 (en) * | 1981-11-24 | 1983-05-27 | Colgate Palmolive Co | TRANSPARENT OR TRANSLUCENT COLORED TOOTHPASTE |
| US4411885A (en) * | 1980-09-30 | 1983-10-25 | Barels Ronald R | Vitamin E oil based dentifrice |
| US4419341A (en) * | 1983-03-04 | 1983-12-06 | Rizhsky Meditsinsky Institut | Drug for treatment of dental caries |
| US4419346A (en) * | 1982-08-13 | 1983-12-06 | Nabisco Brands, Inc. | Method and composition to inhibit the growth of Streptococcus mutans by the use of saccharin/fluoride combination |
| US4515772A (en) * | 1982-06-22 | 1985-05-07 | The Procter & Gamble Company | Oral compositions |
| US4624849A (en) * | 1984-11-02 | 1986-11-25 | The Procter & Gamble Company | Antimicrobial lozenges |
| US4753792A (en) * | 1984-08-21 | 1988-06-28 | Aberg T | Tooth cleaning tablet |
| WO1988010110A1 (en) * | 1987-06-25 | 1988-12-29 | Dentab, Inc. | A tooth cleaning and fluoridating tablet |
| US4806339A (en) * | 1982-06-22 | 1989-02-21 | The Procter & Gamble Company | Oral compositions |
| US4859467A (en) * | 1986-09-25 | 1989-08-22 | Colgate-Palmotive Company | Sustained release fluoride composition |
| US4861590A (en) * | 1986-09-25 | 1989-08-29 | Colgate-Palmolive Company | Sustained release fluoride and calcium composition |
| US4885155A (en) * | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
| US4950479A (en) * | 1986-11-06 | 1990-08-21 | Hill Ira D | Method of interrupting the formation of plaque |
| US4999184A (en) * | 1982-06-22 | 1991-03-12 | The Procter & Gamble Company | Oral compositions |
| US5032387A (en) * | 1986-11-06 | 1991-07-16 | Princeton Pharmaceutical Inc. | Dental and oral hygiene preparations |
| DE4109518A1 (en) * | 1990-03-24 | 1991-09-26 | Yoshimi Adachi | Individual dentifrice supply for direct oral delivery - from water soluble or frangible capsule, ensures use of correct amt. of dentifrice |
| US5057306A (en) * | 1983-11-06 | 1991-10-15 | Hill Ira D | Method of manufacturing oral hygiene gels |
| US5057308A (en) * | 1986-11-06 | 1991-10-15 | Hill Ira D | Method of treating the oral cavity with oral hygiene preparations containing active SnF2 |
| US5057307A (en) * | 1986-11-06 | 1991-10-15 | Hill Ira D | Method of relieving gum discomfort |
| US5057309A (en) * | 1986-11-06 | 1991-10-15 | Hill Ira D | Oral hygiene preparations |
| US5098711A (en) * | 1988-11-14 | 1992-03-24 | Ira Hill | Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
| US5143720A (en) * | 1990-11-28 | 1992-09-01 | Microcide, Inc. | Disinfecting and sanitizing compositions |
| US5158764A (en) * | 1990-10-09 | 1992-10-27 | Degussa | Dentifrice |
| US5165913A (en) * | 1988-11-14 | 1992-11-24 | Ira Hill | Controlled release interproximal delivery system |
| WO1997019668A3 (en) * | 1995-11-27 | 1997-07-24 | Tame Said Jorge Isaac | Toothpaste and mouthwash in tablets |
| US5804165A (en) * | 1996-07-24 | 1998-09-08 | Arnold; Michael J. | Antiplaque oral composition |
| WO1999033437A1 (en) * | 1997-12-29 | 1999-07-08 | The Procter & Gamble Company | Tooth cleaning composition in tablet form |
| US5965110A (en) * | 1990-11-02 | 1999-10-12 | Arnold; Michael J. | Plaque adsorbent oral composition and method |
| JP2000095673A (en) * | 1998-08-18 | 2000-04-04 | Mcneil Ppc Inc | Flexible and chewable tablets |
| US6235318B1 (en) | 1999-01-21 | 2001-05-22 | Charles M. Lombardy, Jr. | Effervescent chewing gum |
| US20040101494A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| US20040101493A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| US20040175334A1 (en) * | 2003-03-06 | 2004-09-09 | Mackinnon Carol L. | Encapsulated dentifrice and method of use |
| US20040223921A1 (en) * | 2003-05-07 | 2004-11-11 | Rau Allen H. | Oral care tablet |
| US20070071817A1 (en) * | 2005-09-26 | 2007-03-29 | Phyzz, Inc. | Effervescent oral care compositions and method of use |
| US7287643B1 (en) * | 2005-01-21 | 2007-10-30 | Glover Sr Larry D | Tooth care device, kit and method of use |
| WO2016156161A1 (en) | 2015-03-30 | 2016-10-06 | Unilever Plc | Solid oral care compositions |
| US20210269227A1 (en) * | 2018-05-14 | 2021-09-02 | The Procter & Gamble Company | Dentifrice Dispenser |
| US20220304919A1 (en) * | 2021-03-25 | 2022-09-29 | The Procter & Gamble Company | Edible Oral Compositions Comprising Hops |
| US11918681B2 (en) | 2019-09-30 | 2024-03-05 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and amino acid |
| US12350355B2 (en) | 2019-09-30 | 2025-07-08 | The Procter & Gamble Company | Oral care compositions comprising hops beta acids and fluoride ions |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US834676A (en) * | 1906-02-23 | 1906-10-30 | Herman C G Luyties | Dentifrice. |
| US840738A (en) * | 1906-05-11 | 1907-01-08 | Woodman Davis Company | Dentifrice. |
| US3116208A (en) * | 1960-11-21 | 1963-12-31 | Sr Joseph S Emond | Dental cleanser in tablet form |
| US3227617A (en) * | 1955-04-25 | 1966-01-04 | Colgate Palmolive Co | Fluoride dentifrice composition |
-
1966
- 1966-07-20 US US566610A patent/US3431339A/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US834676A (en) * | 1906-02-23 | 1906-10-30 | Herman C G Luyties | Dentifrice. |
| US840738A (en) * | 1906-05-11 | 1907-01-08 | Woodman Davis Company | Dentifrice. |
| US3227617A (en) * | 1955-04-25 | 1966-01-04 | Colgate Palmolive Co | Fluoride dentifrice composition |
| US3116208A (en) * | 1960-11-21 | 1963-12-31 | Sr Joseph S Emond | Dental cleanser in tablet form |
Cited By (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3962417A (en) * | 1974-03-27 | 1976-06-08 | Howell Charles J | Dentifrice |
| US4202878A (en) * | 1974-09-20 | 1980-05-13 | The Procter & Gamble Company | Compositions of matter for coloring toothpaste and method of preparing same |
| US4071614A (en) * | 1975-06-03 | 1978-01-31 | Colgate Palmolive Company | Dentifrice containing encapsulated flavoring |
| US4169885A (en) * | 1977-03-19 | 1979-10-02 | Blendax-Werke R. Schneider Gmbh & Co. | Dental and oral hygiene preparations |
| US4203966A (en) * | 1977-08-22 | 1980-05-20 | William F. McCord | Dentifrice with topical and systemic phosphate fluoride system |
| US4157386A (en) * | 1978-05-18 | 1979-06-05 | Rochelle Paul J | Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing |
| US4292306A (en) * | 1978-12-28 | 1981-09-29 | Faunce Frank R | Dentifrice with topical and systemic phosphate fluoride system |
| US4367218A (en) * | 1979-09-06 | 1983-01-04 | Jacobson Jerry I | Anti-caries oral rinse |
| US4308252A (en) * | 1979-10-31 | 1981-12-29 | Young Dental Mfg. Co. | Dentifrice composition |
| US4411885A (en) * | 1980-09-30 | 1983-10-25 | Barels Ronald R | Vitamin E oil based dentifrice |
| FR2516792A1 (en) * | 1981-11-24 | 1983-05-27 | Colgate Palmolive Co | TRANSPARENT OR TRANSLUCENT COLORED TOOTHPASTE |
| US4515772A (en) * | 1982-06-22 | 1985-05-07 | The Procter & Gamble Company | Oral compositions |
| US4806339A (en) * | 1982-06-22 | 1989-02-21 | The Procter & Gamble Company | Oral compositions |
| US4885155A (en) * | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
| US4999184A (en) * | 1982-06-22 | 1991-03-12 | The Procter & Gamble Company | Oral compositions |
| US4419346A (en) * | 1982-08-13 | 1983-12-06 | Nabisco Brands, Inc. | Method and composition to inhibit the growth of Streptococcus mutans by the use of saccharin/fluoride combination |
| US4419341A (en) * | 1983-03-04 | 1983-12-06 | Rizhsky Meditsinsky Institut | Drug for treatment of dental caries |
| US5057306A (en) * | 1983-11-06 | 1991-10-15 | Hill Ira D | Method of manufacturing oral hygiene gels |
| US4753792A (en) * | 1984-08-21 | 1988-06-28 | Aberg T | Tooth cleaning tablet |
| US5057305A (en) * | 1984-08-21 | 1991-10-15 | Dentab, Inc. | Tooth cleaning tablet |
| US4624849A (en) * | 1984-11-02 | 1986-11-25 | The Procter & Gamble Company | Antimicrobial lozenges |
| US4859467A (en) * | 1986-09-25 | 1989-08-22 | Colgate-Palmotive Company | Sustained release fluoride composition |
| US4861590A (en) * | 1986-09-25 | 1989-08-29 | Colgate-Palmolive Company | Sustained release fluoride and calcium composition |
| US5057307A (en) * | 1986-11-06 | 1991-10-15 | Hill Ira D | Method of relieving gum discomfort |
| US5032387A (en) * | 1986-11-06 | 1991-07-16 | Princeton Pharmaceutical Inc. | Dental and oral hygiene preparations |
| US5057308A (en) * | 1986-11-06 | 1991-10-15 | Hill Ira D | Method of treating the oral cavity with oral hygiene preparations containing active SnF2 |
| US4950479A (en) * | 1986-11-06 | 1990-08-21 | Hill Ira D | Method of interrupting the formation of plaque |
| US5057309A (en) * | 1986-11-06 | 1991-10-15 | Hill Ira D | Oral hygiene preparations |
| WO1988010110A1 (en) * | 1987-06-25 | 1988-12-29 | Dentab, Inc. | A tooth cleaning and fluoridating tablet |
| US5098711A (en) * | 1988-11-14 | 1992-03-24 | Ira Hill | Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
| US5165913A (en) * | 1988-11-14 | 1992-11-24 | Ira Hill | Controlled release interproximal delivery system |
| DE4109518A1 (en) * | 1990-03-24 | 1991-09-26 | Yoshimi Adachi | Individual dentifrice supply for direct oral delivery - from water soluble or frangible capsule, ensures use of correct amt. of dentifrice |
| US5158764A (en) * | 1990-10-09 | 1992-10-27 | Degussa | Dentifrice |
| US5965110A (en) * | 1990-11-02 | 1999-10-12 | Arnold; Michael J. | Plaque adsorbent oral composition and method |
| US5280042A (en) * | 1990-11-28 | 1994-01-18 | Microcide, Inc. | Disinfecting and sanitizing compositions |
| US5143720A (en) * | 1990-11-28 | 1992-09-01 | Microcide, Inc. | Disinfecting and sanitizing compositions |
| WO1997019668A3 (en) * | 1995-11-27 | 1997-07-24 | Tame Said Jorge Isaac | Toothpaste and mouthwash in tablets |
| US5804165A (en) * | 1996-07-24 | 1998-09-08 | Arnold; Michael J. | Antiplaque oral composition |
| WO1999033437A1 (en) * | 1997-12-29 | 1999-07-08 | The Procter & Gamble Company | Tooth cleaning composition in tablet form |
| US7029699B2 (en) | 1998-08-18 | 2006-04-18 | Robinson Ronni L | Soft chewable tablets |
| JP2000095673A (en) * | 1998-08-18 | 2000-04-04 | Mcneil Ppc Inc | Flexible and chewable tablets |
| EP0997143A3 (en) * | 1998-08-18 | 2001-11-14 | McNEIL-PPC, INC. | Soft chewable tablets |
| US6471991B2 (en) | 1998-08-18 | 2002-10-29 | Mcneil-Ppc, Inc. | Soft chewable tablets having convexed shaped face surfaces |
| US20030049316A1 (en) * | 1998-08-18 | 2003-03-13 | Robinson Ronni L. | Soft chewable tablets |
| US6235318B1 (en) | 1999-01-21 | 2001-05-22 | Charles M. Lombardy, Jr. | Effervescent chewing gum |
| US20040101494A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| US20040101493A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| US20040175334A1 (en) * | 2003-03-06 | 2004-09-09 | Mackinnon Carol L. | Encapsulated dentifrice and method of use |
| US7074390B2 (en) | 2003-03-06 | 2006-07-11 | Mackinnon Carol L | Encapsulated dentifrice and method of use |
| US8192724B2 (en) * | 2003-05-07 | 2012-06-05 | Tower Laboratories, Ltd. | Oral care tablet |
| US20040223921A1 (en) * | 2003-05-07 | 2004-11-11 | Rau Allen H. | Oral care tablet |
| US20060057078A1 (en) * | 2003-05-07 | 2006-03-16 | Rau Allen H | Oral care tablet |
| US7287643B1 (en) * | 2005-01-21 | 2007-10-30 | Glover Sr Larry D | Tooth care device, kit and method of use |
| US20070071817A1 (en) * | 2005-09-26 | 2007-03-29 | Phyzz, Inc. | Effervescent oral care compositions and method of use |
| WO2016156161A1 (en) | 2015-03-30 | 2016-10-06 | Unilever Plc | Solid oral care compositions |
| US20210269227A1 (en) * | 2018-05-14 | 2021-09-02 | The Procter & Gamble Company | Dentifrice Dispenser |
| US11918681B2 (en) | 2019-09-30 | 2024-03-05 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and amino acid |
| US12350355B2 (en) | 2019-09-30 | 2025-07-08 | The Procter & Gamble Company | Oral care compositions comprising hops beta acids and fluoride ions |
| US20220304919A1 (en) * | 2021-03-25 | 2022-09-29 | The Procter & Gamble Company | Edible Oral Compositions Comprising Hops |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3431339A (en) | Dentifrices | |
| AU615746B2 (en) | Oral compositions | |
| US4923684A (en) | Tripolyphosphate-containing anti-calculus toothpaste | |
| US4985236A (en) | Tripolyphosphate-containing anti-calculus toothpaste | |
| AU632484B2 (en) | Oral compositions | |
| AU715121B2 (en) | Remineralising composition | |
| US3966863A (en) | Oral hygiene compositions | |
| AU597384B2 (en) | Oral hygiene composition containing an antibacterial agent | |
| US3962417A (en) | Dentifrice | |
| US3935305A (en) | Toothpaste | |
| CN1226990C (en) | High water content dentifrice compositions and methods of making the same | |
| AU597199B2 (en) | Oral compositions | |
| CA1148088A (en) | Dental cream compositions containing a binary fluorine-providing system and dicalcium phosphate | |
| EP0258463A1 (en) | Sodium bicarbonate containing toothpaste | |
| US4547362A (en) | Sodium-bicarbonate-containing tooth powder | |
| US6022528A (en) | Oral compositions | |
| JPH11510161A (en) | Oral composition | |
| GB1587608A (en) | Dentifrices | |
| JPH09500101A (en) | Method for producing tartar control baking soda dentifrice | |
| US4663153A (en) | Sodium bicarbonate-containing tooth powder | |
| JPH04234807A (en) | Composition for oral cavity | |
| JPH024207B2 (en) | ||
| JPS59176206A (en) | Sodium hydrogen carbonate-containing dentifrice | |
| JPS63141920A (en) | Dentifrice composition | |
| JP2777804B2 (en) | Oral composition |